[Long-term use of dopamine in shock in patients with massive thromboembolism of the pulmonary artery]. Parkhomenko AN, Sirenko IuN. Vrach Delo. 1989 Mar;(3):43-5. PMID: 2750118
[Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization]. Faggiano P, Rusconi C. G Ital Cardiol. 1991 Nov;21(11):1195-202. PMID: 1809623
Hemodynamic and therapeutic effects of intravenous dopamine. Théroux P, Mizgala HF, Bourassa MG. Can Med Assoc J. 1977 Mar 19;116(6):645-8. PMID: 608165 Free PMC Article Free PMC Article
Toxic cardiogenic shock associated with infusion of 5-fluorouracil. McKendall GR, Shurman A, Anamur M, Most AS. Am Heart J. 1989 Jul;118(1):184-6. doi: 10.1016/0002-8703(89)90095-1. PMID: 2741789
[Hemodynamic effect of dobutamine in cardiogenic shock]. Coma Canella I, López-Sendón J. Rev Esp Cardiol. 1981;34(6):483-9. PMID: 7339730
[Use of adrenergic alpha receptor blockaders (phenoxybenzamine) for the treatment of cardiogenic shock complicating the course of myocardial infarct, under clinical and experimental conditions]. Basistov AF, Glik MS. Kardiologiia. 1973 Aug;13(8):47-50. PMID: 4775153
